Home NDC 68151-4740 Sensipar
Product NDC 68151-4740
11-digit product format 681514740
Labeler code 68151
Product ID 68151-4740_7af108a7-38df-4b45-93ec-15a684a00cb1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cinacalcet hydrochloride
Dosage form TABLET, COATED
Route ORAL
Labeler Carilion Materials Management
Application NDA021688
Marketing category NDA
Marketing start 2004-04-04
Marketing end 0000-00-00
Substance CINACALCET HYDROCHLORIDE
Active strength 30 mg/1
Pharmacologic classes Calcium-sensing Receptor Agonist [EPC],Increased Calcium-sensing Receptor Sensitivity [MoA]
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68151-4740-3 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68151-4740-3 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68151-4740-3 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68151-4740-3 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68151-4740-3 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68151-4740-3 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68151-4740-3 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68151-4740-3 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68151-4740-3 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68151-4740-3 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68151-4740-3 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68151-4740-3 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 68151-4740-3 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 68151-4740-3 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 68151-4740-3 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 68151-4740-3 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 68151-4740-3 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 68151-4740-3 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 68151-4740-3 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 68151-4740-3 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 68151-4740-3 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 68151-4740-3 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021688-001 SENSIPAR CINACALCET HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL RLD 2004-03-08 N021688-002 SENSIPAR CINACALCET HYDROCHLORIDE EQ 60MG BASE TABLET / ORAL RLD 2004-03-08 N021688-003 SENSIPAR CINACALCET HYDROCHLORIDE EQ 90MG BASE TABLET / ORAL RLD 2004-03-08
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 N021688-002 7829595 2026-09-22 U-1098 Drug product N021688-002 9375405 2026-09-22 Drug product 2016-07-22 N021688-003 7829595 2026-09-22 U-1098 Drug product N021688-003 9375405 2026-09-22 Drug product 2016-07-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL RLD 2004-03-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL RLD 2004-03-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL RLD 2004-03-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL RLD 2004-03-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL RLD 2004-03-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL RLD 2004-03-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL RLD 2004-03-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL RLD 2004-03-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL RLD 2004-03-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL RLD 2004-03-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL RLD 2004-03-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL RLD 2004-03-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL RLD 2004-03-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL RLD 2004-03-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL RLD 2004-03-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL RLD 2004-03-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL RLD 2004-03-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL RLD 2004-03-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL AB RLD 2004-03-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL AB RLD, RS 2004-03-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL AB RLD 2004-03-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL AB RLD, RS 2004-03-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL AB RLD 2004-03-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL AB RLD, RS 2004-03-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL AB RLD 2004-03-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL AB RLD, RS 2004-03-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL AB RLD 2004-03-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL AB RLD, RS 2004-03-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL AB RLD 2004-03-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL AB RLD, RS 2004-03-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021688-002 SENSIPAR EQ 60MG BASE TABLET / ORAL AB RLD 2004-03-08 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021688-003 SENSIPAR EQ 90MG BASE TABLET / ORAL AB RLD, RS 2004-03-08 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021688-001 SENSIPAR EQ 30MG BASE TABLET / ORAL AB RLD 2004-03-08 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 102 observed states.
Observed Orange Book patent history# Patent history page 1 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021688-002 7829595 2026-09-22 U-1098 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021688-002 9375405 2026-09-22 Drug product 2016-07-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021688-003 7829595 2026-09-22 U-1098 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021688-003 9375405 2026-09-22 Drug product 2016-07-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-002 7829595 2026-09-22 U-1098 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-002 9375405 2026-09-22 Drug product 2016-07-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-003 7829595 2026-09-22 U-1098 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021688-003 9375405 2026-09-22 Drug product 2016-07-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021688-002 7829595 2026-09-22 U-1098 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021688-002 9375405 2026-09-22 Drug product 2016-07-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021688-003 7829595 2026-09-22 U-1098 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021688-003 9375405 2026-09-22 Drug product 2016-07-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-002 7829595 2026-09-22 U-1098 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-002 9375405 2026-09-22 Drug product 2016-07-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-003 7829595 2026-09-22 U-1098 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021688-003 9375405 2026-09-22 Drug product 2016-07-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-002 7829595 2026-09-22 U-1098 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-002 9375405 2026-09-22 Drug product 2016-07-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-003 7829595 2026-09-22 U-1098 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021688-003 9375405 2026-09-22 Drug product 2016-07-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-002 7829595 2026-09-22 U-1098 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-002 9375405 2026-09-22 Drug product 2016-07-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-003 7829595 2026-09-22 U-1098 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021688-003 9375405 2026-09-22 Drug product 2016-07-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021688-001 7829595 2026-09-22 U-1098 Drug product 2010-12-02 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021688-001 9375405 2026-09-22 Drug product 2016-07-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021688-002 7829595 2026-09-22 U-1098 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021688-002 9375405 2026-09-22 Drug product 2016-07-22 2680178bc6a6…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 45 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68151-4740-3 Sensipar 1 in 1 PACKAGE TABLET, COATED 1 3
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CINACALCET HYDROCHLORIDE ACTIVE INGREDIENT 1K860WSG25 SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 CINACALCET ACTIVE MOIETY UAZ6V7728S SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 CARNAUBA WAX INACTIVE INGREDIENT R12CBM0EIZ SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 POVIDONES INACTIVE INGREDIENT FZ989GH94E SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68151-4740 SENSIPAR (CINACALCET HYDROCHLORIDE) TABLET, COATED [CARILION MATERIALS MANAGEMENT] 3 Legacy NDC, 1 package rows 20160806_8ff022bc-4627-4965-beb1-968deb5b56bc.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Sensipar CINACALCET HYDROCHLORIDE Amgen Inc 45028573-13c4-4c8b-ae62-6c75bba97c81 2025-12-07 Warnings, Adverse reactions Exact identifier application applno (NDA): 021688 application number: NDA021688
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 68151-4740-3 68151474003 1 in 1 PACKAGE Historical